MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.aca.2026.345949

Медицинская библиотека · Analytica chimica acta · 2026

Multiplexed EDL-FET biosensor with tannic acid stabilization for simultaneous p-Tau217 and Aβ42/Aβ40 detection in plasma and whole blood from stroke patients.

Chien Shang-Chi, Chang I-Yin, Chen Yong-Chuan, Lai Yi-Zhen, Chen Yu-Fang, Sun Pei-Lun, Li Bor-Ran, Wang Yu-Lin, Chen Jung-Chih

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Alzheimer's disease (AD) is a leading cause of disability in aging societies, underscoring the need for practical blood-based biomarker assays. Stroke patients face an elevated risk of AD-related cognitive impairment, yet reliable, scalable tools for early biomarker assessment in this population remain lacking. Current platforms are limited by low throughput, instability, and demanding sample preparation that restricts point-of-care translation. This study addresses the need for a multiplexed, clinically practical biosensor capable of simultaneously measuring AD-relevant biomarkers in both plasma and whole blood. An eight-channel electric double-layer field-effect transistor (EDL-FET) platform was developed to simultaneously measure phosphorylated tau (p-tau217) and the Aβ42/Aβ40 ratio in plasma and whole blood. Standardized surface modification with tannic acid (TA)-assisted antibody immobilization enabled stable chip performance under wet storage for at least 10 days. Clinically, 54 plasma and 32 whole-blood samples from stroke patients were stratified into cognitively impaired (MMSE ≤24) and unimpaired (MMSE >24) groups. p-tau217 significantly differentiated cognitive status in both matrices, with the strongest performance in plasma. Combining p-tau217 with Aβ42/Aβ40 in plasma yielded a receiver operating characteristic (ROC) area under the curve (AUC) of 0.938. Plasma p-tau217, alone or in combination, demonstrated higher sensitivity for detecting cognitive impairment, while whole-blood measurements offered practicality, with preserved sample integrity and minimal pre-analytical requirements. This work presents the first multiplexed EDL-FET platform for simultaneous AD biomarker profiling in stroke patients using both plasma and whole blood. The integration of p-tau217 and Aβ42/Aβ40 on a stable, multi-channel chip demonstrates a novel route toward point-of-care AD risk stratification in high-risk populations, pending validation in larger, multi-center cohorts.

Для цитирования: Chien Shang-Chi, Chang I-Yin, Chen Yong-Chuan, Lai Yi-Zhen, Chen Yu-Fang, Sun Pei-Lun, Li Bor-Ran, Wang Yu-Lin, Chen Jung-Chih. Multiplexed EDL-FET biosensor with tannic acid stabilization for simultaneous p-Tau217 and Aβ42/Aβ40 detection in plasma and whole blood from stroke patients.. Analytica chimica acta. 2026. DOI: 10.1016/j.aca.2026.345949.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.